Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy

BACKGROUND: Glutamine synthetase (GS) and arginase 1 (Arg1) are widely used pathological markers that discriminate hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma; however, their clinical significance in HCC remains unclear. METHODS: We retrospectively analyzed 431 HCC patients:...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Mingyang, Tao, Qing, Xu, Yahong, Xu, Qing, Shu, Yuke, Chen, Yuwei, Shen, Junyi, Zhou, Yongjie, Wu, Zhenru, Chen, Menglin, Yang, Jiayin, Shi, Yujun, Wen, Tianfu, Bu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476731/
https://www.ncbi.nlm.nih.gov/pubmed/37249521
http://dx.doi.org/10.1097/CM9.0000000000002380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476731/
https://www.ncbi.nlm.nih.gov/pubmed/37249521
http://dx.doi.org/10.1097/CM9.0000000000002380

Ejemplares similares